文献速递白血病

T系急性淋巴细胞白血病的分类与风险分层

Classification and risk stratification in T-lineage acute lymphoblastic leukemia.
PubMed 文献 · Blood · 2025-01-01

本文综述了T系急性淋巴细胞白血病(T-ALL)的风险分层现状。年龄、中枢神经系统受累和可测量残留病(MRD)反应是跨试验验证的预后因素;免疫表型(含早期前T细胞ALL)虽广泛用于分类,但在多变量风险模型中与结局关联不一致;近期大规模基因组分析识别出多个独立于MRD的遗传亚型与改变,基于基因组学的分类有望指导未来治疗策略。

要点

  • 年龄、中枢神经系统受累和MRD反应是T-ALL中经临床试验和真实世界数据验证的预后因素。
  • 免疫表型(包括早期前T细胞ALL)广泛用于分类,但在多变量风险模型中与结局的关联不一致。
  • 近期大规模基因组分析识别出多个独立于MRD的遗传亚型与改变,基于基因组学的分类有潜力指导未来T-ALL治疗策略。

核心结论

  • 本综述强调识别可靠预后生物标志物的持续努力,并指出基于基因组学的分类有潜力指导未来T-ALL治疗策略。

研究设计与样本

  • 综述,聚焦T-ALL风险分层与分类的现有证据与近期进展。

主要发现

  • 年龄、中枢神经系统受累和MRD反应是在T-ALL临床试验和真实世界数据中验证的预后因素。
  • 免疫表型(包括早期前T细胞ALL)广泛用于分类T-ALL,但在多变量风险模型中与结局的关联不一致。
  • 历史上少有遗传改变与结局一致相关,但近期全面的大规模基因组分析识别出多个独立于MRD、与结局相关的遗传亚型和改变。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cure rates for patients with acute lymphoblastic leukemia (ALL) have improved markedly in recent decades, in part because of risk stratification incorporating leukemia genomics, response to treatment, and clinical features to be able to determine at diagnosis which patients are more likely to relapse or have refractory disease. Although risk stratification is well developed for patients with B-lineage ALL, it remains challenging for those with T-lineage ALL (T-ALL). Prognostic factors validated across clinical trials and real-world data in T-ALL include age, central nervous system involvement, and measurable residual disease (MRD) response. Immunophenotype, including early T-cell precursor ALL, is widely used to classify T-ALL but is not consistently associated with outcome in multivariable risk models. Historically, few genetic alterations have been consistently associated with outcome, but recent comprehensive, large-scale genomic profiling has identified multiple genetic subtypes and alterations associated with outcome independent of MRD. This review highlights ongoing efforts to identify reliable prognostic biomarkers and underscores the potential of genomics-based classification to guide future T-ALL treatment strategies.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Pölönen P, Mullighan CG, Teachey DT, et al. Classification and risk stratification in T-lineage acute lymphoblastic leukemia. Blood. 2025. PMID: 39357057. doi:10.1182/blood.2023022920

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。